ArticlePediatric nephrology (Berlin, Germany)2025

Eculizumab as first-line treatment for patients with severe presentation of complement factor H antibody-mediated hemolytic uremic syndrome.

Paula A Coccia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.